1Park DC, Hertzog C, Leventhal H, et al. Medication adherence in rheumatoid arthritis: older is wiser. J Am Geriatr Soc, 1999,47: 172-183.
2Apter A J, Reisine ST, Affieck G, et al. Adherence with twice- daily dosing of inhaled steroids : socioeconomic and health-belief differences. Am J Respir Crit Care Med, 1998,157: 1810-1817.
3Horwitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet, 1990, 336 : 542-545.
4Hu Y, Yang L J, Wei L, et al. Study on the compliance and safety of the oral antifungal agents for the treatment of onychomycosis. Chin J Epidemiol,2005,26(12) :988-991. (in Chinese).
5Zeichner JA, Lebwohl MG, Menter A, et al. Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis, 2010,86(3 Suppl) : S5-31.
6Caon C, Saunders C, Smrtka J, et al. Injectable disease- modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data. J Neurosci Nurs, 2010,42 (5 Suppl) $5-9.
7Finlay AY, Khan GK. Dermatology life quality index (DLQI)-- a simple practical measure for routine clinical use. Clin Exp Dermatol, 1994,19:210-216.
8Granger BB, Swedberg K, Ekman I, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme~ double-blind, randomised, controlled clinical trial. Lancet, 2005,366 (9502) : 2005-2011.
9Coronary Drug Project Reserch Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med, 1980,303:1038-1041.
10Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med, 1993,153 : 1863-1868.
